All the latest Form happenings. Want to stay in the loop? Subscribe Now
She succeeds co-founders Andrew Busey, CEO, and President and COO Kent Wakeford, who have led the Texas-based biotech since its 2022 spinout from Colossal Biosciences.
Proven technology driven biotech leader to accelerate company's next phase of AI-powered growth in genetic medicine and genome engineering
Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster.
Karen Jagoda sits down with Kent Wakeford, Co-CEO & Co-Founder of Form Bio on the Empowered Patient Podcast to discuss how computational biology is accelerating cell & gene therapy development.
From de-extinction to life saving AAV gene therapies, Form Bio is applying breakthrough AI technologies to advance scientific discovery.
